149 related articles for article (PubMed ID: 25388166)
21. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
[TBL] [Abstract][Full Text] [Related]
22. Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.
Karacetin D; Yalcin B; Okten B; Ozturk S; Maral O; Incekara O
J BUON; 2009; 14(4):605-8. PubMed ID: 20148449
[TBL] [Abstract][Full Text] [Related]
23. Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma.
Usakova V; Sevcikova K; Usak J; Bartosova Z; Mikulova M; Spanik S
Neoplasma; 2013; 60(1):83-91. PubMed ID: 23067221
[TBL] [Abstract][Full Text] [Related]
24. The Predictive Role of ERCC1 Status in Oxaliplatin Based Neoadjuvant Therapy for Metastatic Colorectal Cancer (mCRC) to the Liver.
Geva R; Shamai S; Brazowsky E; Paoulas M; Ben-Haim M; Johnstone E; Alex B; Shacham-Shmueli E
Cancer Invest; 2015 Apr; 33(4):89-97. PubMed ID: 25723812
[TBL] [Abstract][Full Text] [Related]
25. Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer.
Tsutsumi S; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Asao T; Kuwano H
Hepatogastroenterology; 2014 May; 61(131):633-7. PubMed ID: 26176048
[TBL] [Abstract][Full Text] [Related]
26. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
Siesing C; Sorbye H; Dragomir A; Pfeiffer P; Qvortrup C; Pontén F; Jirström K; Glimelius B; Eberhard J
PLoS One; 2017; 12(8):e0182512. PubMed ID: 28800641
[TBL] [Abstract][Full Text] [Related]
27. Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer.
Cristóbal I; González-Alonso P; Daoud L; Solano E; Torrejón B; Manso R; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Mar Drugs; 2015 May; 13(6):3276-86. PubMed ID: 26023836
[TBL] [Abstract][Full Text] [Related]
28. A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.
Vicente C; Arriazu E; Martínez-Balsalobre E; Peris I; Marcotegui N; García-Ramírez P; Pippa R; Rabal O; Oyarzábal J; Guruceaga E; Prósper F; Mateos MC; Cayuela ML; Odero MD
Cancer Lett; 2020 Jan; 468():1-13. PubMed ID: 31593801
[TBL] [Abstract][Full Text] [Related]
29. Low Skeletal Muscle Mass before Salvage-Line Chemotherapy Is a Poor Prognostic Factor in Patients with Refractory Metastatic Colorectal Cancer.
Miyamoto Y; Hiyoshi Y; Akiyama T; Kiyozumi Y; Eto K; Yohei N; Iwagami S; Baba Y; Yoshida N; Baba H
Digestion; 2019; 99(1):79-85. PubMed ID: 30554226
[TBL] [Abstract][Full Text] [Related]
30. Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
Lu M; Zessin AS; Glover W; Hsu DS
PLoS One; 2017; 12(1):e0169439. PubMed ID: 28060954
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Wang EN; Maeda K; Hirakawa K; Ohira M
Anticancer Res; 2019 Feb; 39(2):1051-1057. PubMed ID: 30711994
[TBL] [Abstract][Full Text] [Related]
32. Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC).
Heinemann V; Stintzing S; Modest DP; Giessen-Jung C; Michl M; Mansmann UR
Eur J Cancer; 2015 Sep; 51(14):1927-36. PubMed ID: 26188850
[TBL] [Abstract][Full Text] [Related]
33. The interaction of SET and protein phosphatase 2A as target for cancer therapy.
Dacol EC; Wang S; Chen Y; Lepique AP
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188578. PubMed ID: 34116173
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia.
Cristóbal I; Garcia-Orti L; Cirauqui C; Cortes-Lavaud X; García-Sánchez MA; Calasanz MJ; Odero MD
Haematologica; 2012 Apr; 97(4):543-50. PubMed ID: 22133779
[TBL] [Abstract][Full Text] [Related]
35. FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer.
Li J; Wang SW; Zhang DS; Sun Y; Zhu CY; Fei Q; Hu J; Zhang C; Sun YM
Oncol Rep; 2016 May; 35(5):2833-42. PubMed ID: 26985637
[TBL] [Abstract][Full Text] [Related]
36. Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients.
Oh BY; Lee WY; Jung S; Hong HK; Nam DH; Park YA; Huh JW; Yun SH; Kim HC; Chun HK; Cho YB
Oncotarget; 2015 Jun; 6(18):16059-68. PubMed ID: 25965827
[TBL] [Abstract][Full Text] [Related]
37. PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
Stafman LL; Williams AP; Marayati R; Aye JM; Stewart JE; Mroczek-Musulman E; Beierle EA
PLoS One; 2019; 14(4):e0214469. PubMed ID: 30969990
[TBL] [Abstract][Full Text] [Related]
38. The therapeutic effects of SET/I2PP2A inhibitors on canine melanoma.
Enjoji S; Yabe R; Fujiwara N; Tsuji S; Vitek MP; Mizuno T; Nakagawa T; Usui T; Ohama T; Sato K
J Vet Med Sci; 2015 Nov; 77(11):1451-6. PubMed ID: 26062569
[TBL] [Abstract][Full Text] [Related]
39. Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer.
Hung MH; Chen KF
Expert Opin Ther Targets; 2017 Jul; 21(7):685-694. PubMed ID: 28548025
[TBL] [Abstract][Full Text] [Related]
40. Pathologic significance of SET/I2PP2A-mediated PP2A and non-PP2A pathways in polycystic ovary syndrome (PCOS).
Jiang SW; Xu S; Chen H; Liu X; Tang Z; Cui Y; Liu J
Clin Chim Acta; 2017 Jan; 464():155-159. PubMed ID: 27836688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
